← peptides typeshit

WHO advises against GLP-1 drugs for children 9 and under as pediatric trials continue

New WHO childhood obesity guidance cites unknown effects on growth and mental health, while Novo, Lilly, AstraZeneca and Pfizer keep testing the drugs in kids.

Read at Yahoo

Recap by typeshit. Full story at Yahoo.